US Patent Issued to Verseau Therapeutics on Feb. 17 for "Anti-PSGL-1 compositions and methods for modulating myeloid cell inflammatory phenotypes and uses thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,552,873, issued on Feb. 17, was assigned to Verseau Therapeutics Inc. (Bedford, Mass.).

"Anti-PSGL-1 compositions and methods for modulating myeloid cell inflammatory phenotypes and uses thereof" was invented by Tatiana I. Novobrantseva (Wellesley, Mass.), Igor Feldman (Waltham, Mass.), Stephen L. Sazinsky (Melrose, Mass.), Joseph A. Wahle (Belmont, Mass.), Brian O'Nuallain (Needham, Mass.) and Ryan Phennicie (Andover, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is based, in part, on the discovery of anti-PSGL-1 compositions (e.g., monoclonal antibodies and antigen-binding fragments thereof) that regulate myeloid cell infl...